Introduction: Bovine mycoplasma, chiefly Mycoplasma bovis, is a pathogen that causes pneumonia, mastitis, arthritis, and otitis media in cattle. This pathogen exerts immunosuppressive effects, such as the inhibition of interferon production. However, the mechanisms involved in bovine mycoplasmosis have not been fully elucidated. In this study, we investigated the role of the programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) pathway in immunosuppression in bovine mycoplasmosis. Methods: In the initial experiments, we used enzyme-linked immunosorbent assay to measure interferon-g (IFN-g) from peripheral blood mononuclear cells (PBMCs) isolated from cattle with mycoplasmosis. Results: Expectedly, IFN-g production significantly decreased in cattle with mycoplasmosis compared with that in clinically healthy cattle. Concomitantly, flow cytometric analysis revealed that the proportions of PD-1
Introduction
Bovine mycoplasmosis is a disease of cattle characterized by chronic pneumonia, therapy-resistant mastitis, otitis media, and arthritis [1] [2] [3] . Many mycoplasmas such as Mycoplasma bovis, Mycoplasma mycoides subsp. mycoides biotype Small Colony (MmmSC), Mycoplasma bovigenitalium, Mycoplasma californicum, are known to have pathogenicity against cattle [2] [3] [4] . In recent years, outbreaks of such diseases, especially of those caused by M. bovis, have been frequently reported worldwide, including in Japan, and have had significant economic impacts on the cattle industry [2, 3, 5, 6] . Once clinical symptoms develop, it is difficult to completely cure the disease, resulting in calf mortality, weight loss in surviving calves, and decreased milk production in dairy cows [1] [2] [3] . In addition, there are no effective vaccines against bovine mycoplasmas except for MmmSC; therefore, it is difficult to control this infection [4] . Thus, there is a critical need to develop improved preventative and therapeutic strategies for this disease. This pathogen exerts several immunosuppressive effects in vitro, such as inhibition of bovine peripheral blood mononuclear cell (PBMC) proliferation, induction of bovine lymphocyte apoptosis, and delay of bovine monocyte apoptosis, along with suppression of interferon (IFN)-g and tumor necrosis factor (TNF)-a production [7] [8] [9] . These characteristics could be associated with disease progression of bovine mycoplasmosis. However, immunosuppression mechanisms involved in bovine mycoplasmosis have not yet been fully elucidated.
Dysfunction of antigen-specific T cells called T-cell exhaustion has been shown to be involved in immunosuppression during various chronic infections [10] [11] [12] . Exhausted T cells lose their effector functions and are phenotypically characterized by the surface expression of immunoinhibitory receptors such as programmed death 1 (PD-1) [10] . PD-1 is expressed on the surface of activated lymphocytes, and PD-ligand 1 (PD-L1), a ligand for PD-1, is expressed widely on several cells including activated lymphocytes, dendritic cells, and monocytes. Binding of PD-1 to PD-L1 transmits inhibitory signals into cells, subsequently exhausts T cell signaling, and induces immunosuppression [10] . Recent studies have indicated the PD-1/PD-L1 interactions have been closely associated with the inhibition of chronically activated pathogen-specific T cells and induction of T-cell exhaustion [11] [12] [13] [14] .
Previous studies on chronic bovine infections, such as bovine leukemia virus infection, Johne's disease, and bovine anaplasmosis, revealed that the upregulation of bovine PD-1 and other immunoinhibitory receptors on T cells was closely associated with the exhaustion of T-cell responses and disease progression [15] [16] [17] [18] [19] [20] . Moreover, blockade of the PD-1/PD-L1 pathway reactivated T-cell functions such as proliferation and cytokine production in vitro [15, [17] [18] [19] [20] . However, the expression of PD-1/PD-L1 and their functions in bovine mycoplasmosis have not been investigated. In the present study, we determined whether the PD-1/PD-L1 pathway downregulates M. bovis-specific T-cell responses during bovine mycoplasmosis. In these analyses, PD-1/PD-L1-expressing immunocytes increased in the peripheral blood of bovine mycoplasma-infected cattle. Increased PD-1-expressing T cells were associated with decreased IFN-g production from bovine PBMCs. Furthermore, in vitro blockade using anti-PD-1 monoclonal antibodies (mAbs) or anti-PD-L1 mAbs restored IFN-g production from PBMCs stimulated by M. bovis antigens. The present data indicate that exhausted T cells induced by PD-1/PD-L1 interactions could contribute to the immunosuppression of bovine mycoplasmosis and suggest that PD-1 and PD-L1 are molecular targets for the control of bovine mycoplasma-specific T-cell responses.
Materials and Methods

Bovine samples and cell preparation
Peripheral blood samples of cattle with clinical symptoms were obtained from adult Holstein-breed cattle in Hokkaido, Japan. Cattle infected with M. bovis were clinically and microbiologically diagnosed at the Animal Medical Center, School of Veterinary Medicine, Rakuno Gakuen University, in 2016. The symptoms of the infected cattle were pneumonia, arthritis, and otitis media. M. bovis infection was confirmed with PCR by using clinical samples as previously described [21] . Control blood samples were collected from clinically healthy cattle with no history of mycoplasmosis maintained at the Field Science Center for Northern Biosphere, Hokkaido University, or at dairy farms in Hokkaido. All of control cattle were serologically negative for M. bovis infection by using enzyme-linked immunosorbent assay (ELISA). Briefly, flat-bottom 96-well plates (Thermo Fisher Scientific, Waltham, MA) were coated with 100 ml of solubilized M. bovis (PG45, ATCC 25523, 50 mg/mL in carbonate buffer) as the target antigen at 378C for 17 h. After the plates were four times washed with a wash solution (PBS with 0.1%Tween20), 100 ml of serum samples were added on each plate. After 378C for 1 h incubation, plates were three times washed with a TSB-T (PBS with 50 mM Tris, 0.1%BSA and 0.05%Tween20) and incubated with a skim milk (Wako, Osaka, Japan) as protein blocker for 2 h at 378C. After three times washed with a TSB-T, protein-G conjugated horseradish peroxidase (Rockland, ME) were added to the wells and incubated 1h at 378C. After three times washed with a TSB-T, 3-ethylbenzothiazolin-6-sulfonic Acid (ABTS; Sera care, USA) were added to the wells and measured 415 nm optical density (OD) using plate reader (iMark TM Microplate Absorbance Reader, Bio-Rad, Hercules, CA). Bovine PBMCs were purified from blood samples with density gradient centrifugation on Percoll (GE Healthcare, Buckinghamshire, UK).
IFN-g assay
To examine the decrease in IFN-g production in bovine mycoplasmosis, purified PBMCs were incubated with antibovine CD3 antibody (2 mg/mL; MM1A, Washington State University Monoclonal Antibody Center, Pullman, WA) and anti-bovine CD28 antibody (2 mg/mL; CC220, Bio-Rad) in RPMI 1640 medium (Sigma-Aldrich, St. Louis, MO) containing 10% fetal calf serum (FCS; Thermo Fisher Scientific) and 100 IU/mL penicillin, 100 mg/mL streptomycin, and 2 mM L-glutamine (Thermo Fisher Scientific) at 378C under 5% CO 2 for 5 days. Collected culture supernatants were assayed for IFN-g using an ELISA kit (Mabtech, Nacka Strand, Sweden), in accordance with the manufacturer's instructions. Data are presented as means of duplicate samples.
Flow cytometric analysis of PD-1 and PD-L1
To examine the expression levels of PD-1 and PD-L1 in bovine mycoplasmosis, purified PBMCs were analyzed with flow cytometry. PBMCs were isolated from blood and incubated in PBS containing 10% goat serum (SigmaAldrich) at room temperature for 15 min to prevent nonspecific reactions. Cells were then washed and stained with anti-bovine PD-1 mAb (5D2, rat IgG2a; 15) or rat IgG2a isotype control (R35-95, BD Biosciences, San Jose, CA) for 30 min at room temperature. After being washed with PBS containing 1% bovine serum albumin (BSA) (Sigma-Aldrich), cells were stained with FITC-conjugated anti-CD4 mAb (CC8, Bio-Rad), R-PE-conjugated anti-CD8 mAb (CC63, Bio-Rad), PerCp/Cy5.5-conjugated anti-CD3 mAb (MM1A, Washington State University Monoclonal Antibody Center), PE/Cy7-conjugated antiIgM mAb (IL-A30, Bio-Rad), and APC-conjugated anti-rat immunoglobulin antibody (Southern Biotech, Birmingham, AL) antibody conjugates for 30 min at room temperature. Before the staining, MM1A and IL-A30 were conjugated with PerCp/Cy5.5 and PE/Cy7, respectively, using Lightning-Link conjugation kits (Innova Biosciences, Cambridge, UK). Stained cells were then washed and immediately analyzed using FACS Verse (BD Biosciences) and FCS Express 4 (De Novo Software, Glendale, CA). To detect PD-L1-expressing cells, PBMCs were blocked with PBS containing 10% goat serum and washed and stained with anti-bovine PD-L1 mAb (4G12, rat IgG2a; 20) or rat IgG2a isotype control (R35-95, BD Biosciences) in the presence of anti-CD11b mAb (CC126, mouse IgG2b, Bio-Rad) for 30 min at room temperature. After washing with PBS containing 1% BSA, cells were stained with APC-Cy7-conjugated anti-CD14 mAb (CAM36A: Washington State University Monoclonal Antibody Center) using the Lightning-Link APC-Cy7 tandem conjugation kit (Innova Biosciences), APCconjugated anti-rat immunoglobulin antibody (Southern Biotech), and FITC-conjugated anti-mouse IgG2b antibody (Beckman Coulter, Fullerton, CA) antibody conjugates for 30 min at room temperature. Cells were then washed and immediately analyzed using FACS Verse (BD Biosciences) and FCS Express 4 (De Novo Software) as above.
Blockade assay
To investigate the influence of PD-1/PD-L1 blockade, PBMCs were incubated with 10 mg/mL anti-bovine PD-1 mAb (5D2; 15) or anti-bovine PD-L1 mAb (4G12; 20) in the presence of 1.5 mg/mL heat-killed M. bovis (PG45, ATCC 25523). Rat IgG (Sigma-Aldrich) was used as a control antibody. All antibodies used in blockade assay were suspended in endotoxin-free sterile PBS (Wako) without azide. PBMC cultures were grown in 96-well plates (Corning, Inc., Corning, NY) at 378C with 5% CO 2 for 5 days. Subsequently, culture supernatants were harvested from individual wells and were tested for a bovine IFN-g ELISA (Mabtech) as described above.
Statistics
Differences were identified using Wilcoxon's matched pairs test and Spearman's rank test. Steel-dwass test was used to compare the expression of PD-1 and PD-L1 among types of mycoplasmosis with different clinical symptoms. All statistical tests were performed using the statistical analysis program MEPHAS (http://www.gen-info.osaka-u.ac.jp/ MEPHAS/). P values of <0.05 were considered significant.
Results
Reduction in the IFN-g production in bovine mycoplasmosis
The median IFN-g in supernatant of cultivated PBMCs that were stimulated with anti-CD3 and anti-CD28 antibodies in the cattle with mycoplasmosis was significantly lower than that in the healthy cattle (P < 0.01) (Fig. 1) . No significant differences were observed in IFN-g production among the different clinical symptoms (pneumonia, arthritis, and otitis media) in the M. bovis-infected cattle (data not shown).
Upregulation of PD-1/PD-L1 expression in bovine mycoplasmosis
To investigate PD-1 expression in bovine mycoplasmosis, we examined the proportions of PD-1 þ cells among PBMCs freshly isolated from M. bovis-infected cattle with pneumonia, arthritis, or otitis media. The median proportion of PD-1 þ CD4 þ ( Fig. 2A) among PBMCs isolated from cattle with mycoplasmosis were higher than those from healthy control cattle. In addition to this, there was approaching significance difference in proportion of PD-1 þ CD8 þ T cells between M. bovis-infected cattle and control cattle (P ¼ 0.051) (Fig. 2B) . Similarly, the median proportion of PD-L1 þ CD11b þ CD14 þ cells was higher in cattle with mycoplasmosis than in control cattle (P < 0.05) (Fig. 2C) . No significant differences were observed in PD-1 and PD-L1 expressions among the types of mycoplasmosis with different clinical symptoms in the M. bovis-infected cattle, although all of the median proportions of PD-1 þ CD4 þ (Fig. 3A) , PD-1 þ CD8 þ (Fig. 3B) , and PD-L1 þ CD11b þ CD14 þ cells (Fig. 3C ) were higher than those of healthy control cattle. Interestingly, the increases in the proportion of PD-1
T cells negatively correlated with IFN-g production from PBMCs in infected cattle ( Fig. 4A and B) .
Reactivation of IFN-g production by PD-1/PD-L1 blockade
To test the effect of the PD-1/PD-L1 blockade on M. bovisspecific immune response, PBMCs from M. bovis-infected cattle were cultivated in the presence of heat-killed M. bovis together with anti-PD-1, anti-PD-L1, or an isotype control antibody. IFN-g production was significantly augmented in cells treated with the anti-PD-1 antibody compared with those treated with the control antibody (Fig. 5A) . Similarly, the blockade by anti-PD-L1 antibody also enhanced IFN-g production from PBMCs stimulated with M. bovis (Fig. 5B) .
Discussion
During chronic infection, pathogens evade host immune responses and persist after the effector phase [22, 23] , leading to persistent antigen stimulation and progressive T-cell dysfunction known as T-cell exhaustion [10] . Exhausted T cells are controlled by the immunoinhibitory receptor PD-1 on the cell surface via T-cell inhibitory signals that follow crosslinking to the ligand PD-L1 [13] . Previous studies revealed that the expression of PD-1 was upregulated on exhausted T cells in various bovine chronic infections such as bovine leukemia virus infection, Johne's disease, and bovine anaplasmosis [15] [16] [17] . T cells expressing these receptors show low effector functions and allow chronic pathogens to establish persistent infection. Therefore, T-cell exhaustion is regarded as the common mechanism of immune evasion in chronic infections. In bovine mycoplasmosis, it is well-known that pathogens, chiefly M. bovis, exert immunosuppressive effects in vitro [7] [8] [9] . Because of these characteristics, it is suspected that this disease develops to chronic progression and, especially during lung infection, allows to establish coinfection with other bacteria and other pathogens such as viruses [2] . However, the mechanisms involved in bovine mycoplasmosis have not yet been fully elucidated. In this study, we investigated the role of the PD-1/PD-L1 pathway in immunosuppression in cattle infected with bovine mycoplasma.
IFN-g is a Th1 cytokine mediating a cellular immune response by promoting the activation and proliferation of macrophages. In contagious bovine pleuropneumonia caused by MmmSC, a positive correlation between the number of MmmSC-specific IFN-g-secreting CD4
þ T cells and the recovery from the disease was identified [24, 25] . Therefore, IFN-g production might be important for protection against bovine mycoplasmosis. In the current study, M. bovis-specific IFN-g production from PBMCs decreased in cattle with bovine mycoplasmosis compared with that healthy control cattle. This suggested that the Figure 1 . IFN-g production in bovine mycoplasmosis. IFN-g production was determined in supernatant of the PBMCs culture from mycoplasmosis-afflicted and healthy control Holstein cattle by ELISA assay. PBMCs were incubated with the combination of anti-bovine CD3 and antibovine CD28 antibodies. Each line indicates the median production in each group.
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immune response against M. bovis might not be effective during bovine mycoplasmosis.
In the present study, PD-L1 expression on CD14 þ CD11b þ monocytes and PD-1 expression on CD4 þ T cells was found to be upregulated in bovine mycoplasmosis. We also compared PD-1 or PD-L1 expression among different conditions of bovine mycoplasmosis. There were no significant differences among the different conditions, but the proportions of PD-1-or PD-L1-expressing cells in all conditions increased compared with those in healthy cattle. Moreover, lower proportions of circulating PD-1 þ cells strongly correlated with increased IFN-g levels. This indicates that decreased levels of IFN-g during the progression of bovine mycoplasmosis could be due to the increased number of PD-1 þ cells. These results suggest that the PD-1/PD-L1 pathway could be involved in immune exhaustion of bovine mycoplasma-specific T cells. In chronic infections, the expression of PD-1 is induced by continuous antigen presentation and T-cell receptor stimulation [10, 13] . Thus, PD-1 was hypothesized to be upregulated on M. bovis antigen-specific T cells, causing effector function loss in these cells.
The mechanism of PD-L1 upregulation during bovine mycoplasmosis remains unknown. In HIV models, the cytokine microenvironment was proposed as one of the mechanisms by which PD-L1 expression is elevated [26] . This hypothesis might contribute to understanding the mechanism of PD-L1 upregulation during mycoplasmosis, considering the changes in the cytokine microenvironment [27] [28] [29] . Nevertheless, further elucidation of the mechanism underlying the elevation of PD-L1 expression is Figure 1A (n ¼ 15). Correlation statistics were analyzed using Spearman's correlation.
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warranted to obtain a comprehensive understanding of cell signaling pathways involved in the modulation of host immune responses.
In vitro blockade assays of PD-1/PD-L1 pathway in PBMCs showed that blockade with anti-PD-1 and anti-PD-L1 mAbs efficiently reactivated the M. bovis-specific IFN-g response. It is noteworthy that the blockade of the PD-1/PD-L1 pathway restored anti-mycoplasma immune functions in vitro. The results obtained in this study were consistent with those in other bovine diseases, such as bovine leukemia virus (BLV) infection, Johne's disease, and bovine anaplasmosis [15, 17, 18] .
For use in humans, PD-1/PD-L1 pathway-targeting biopharmaceuticals have been successively developed. Recently, we established an anti-bovine PD-L1 rat-bovine chimeric antibody, and clinical study was conducted in BLV infection. Interestingly, the tested calf indicated that the proliferation of anti-BLV-specific CD4 þ T cells was increased by the chimeric antibody inoculation, while BLV provirus loads were significantly reduced, clearly demonstrating that this treatment induced antivirus activities [30] .
The current results also suggest that blockade of the PD-1/ PD-L1 pathway might be an effective method for controlling bovine mycoplasmosis. Here, we examined M. bovis-specific IFN-g production as a key response of Th1-mediated immunity and described novel mechanisms of T-cell exhaustion mediated by immunoinhibitory receptors in bovine mycoplasmosis. However, additional studies are required to determine multiple effects of blocking mAbs during the rejuvenation of T-cell exhaustion. Specifically, measurements of other Th1 cytokines, such as TNF-a, interleukin (IL)-2, and IL-12, and of T-cell proliferation and cytotoxic activity may reveal further aspects of T-cell exhaustion in bovine mycoplasmosis. The present findings may contribute to the development of novel strategies for manipulating bovine mycoplasmaspecific T-cell responses to prevent disease progression.
